Why is the language developers and DBAs use to organize data such a mess? Here are 13 reasons we wish we could quit SQL, even though we probably won't. For all its popularity and success, SQL is a ...

There's a new player in the AI race, and it's a whole country. Switzerland has just released Apertus, its open-source national Large Language Model (LLM) that it hopes would be an alternative to ...

Abstract: Salt domes are very important in hydrocarbon exploration and identification of potential drilling hazards. While seismic data are indispensable for detailed subsurface imaging, especially in ...

Open-source data analytics platforms offer cost-effective, customizable solutions for all business sizes. These tools rival paid options in features like visualization, automation, and big data ...

The International Progressive MS Alliance announces the launch of its MS Clinical and Imaging Data Resource (CIDR), which provides the academic and research community access to anonymized and ...

Versant is rebranding MSNBC and changing the logos of other networks in its portfolio as it looks to distinguish itself from NBCUniversal ahead of its separation from Comcast by the end of this year. ...

Liz Simmons is an education staff writer at Forbes Advisor. She has written about higher education and career development for various online publications since 2016. She earned a master’s degree in ...

Mississippi residents spend a higher percentage of their income on groceries than any other state, despite having some of the lowest grocery costs. This high percentage (10.57%) is due to the state's ...

Patch Tuesday: Microsoft Addresses 137 Vulnerabilities, Including High-Severity SQL Server RCE Your email has been sent Two SQL Server vulnerabilities raise concerns for data exposure and remote code ...

The clock is ticking and you've got less than 2 weeks left to file a claim and get part of the 23andMe class-action settlement. Thomas is a native of upstate New York and a graduate of the University ...

Almost two years of treatment with fenebrutinib — an investigational oral tablet for multiple sclerosis (MS) — helped patients with relapsing forms of the disease remain nearly free of relapses and ...